MedPath

Hyoscyamine Sulfate

Hyoscyamine Sulfate Orally Disintegrating Tablets, 0.125 mg Rx Only

Approved
Approval ID

7cd2c973-d066-4948-494f-bda7b80e5b14

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 4, 2022

Manufacturers
FDA

Alvogen Inc.

DUNS: 008057330

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Hyoscyamine Sulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code47781-012
Product Classification
G
Generic Name
Hyoscyamine Sulfate
Product Specifications
Route of AdministrationORAL
Effective DateMarch 4, 2022
FDA Product Classification

INGREDIENTS (6)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CROSPOVIDONE (120 .MU.M)Inactive
Code: 68401960MK
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
SORBITOLInactive
Code: 506T60A25R
Classification: IACT
HYOSCYAMINE SULFATEActive
Quantity: 0.125 mg in 1 1
Code: F2R8V82B84
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Hyoscyamine Sulfate - FDA Drug Approval Details